| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbb7c566de48ddc2f6ab493710ddc328 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate |
2003-08-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc61bcc46111b6a63a88b4e5fe5bf257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a58da8a1f1abcb9ec47ae9328e09980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a2040dc1fb55d7d36c86443b9b5647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df41c9c43fb0067ddd65ef433f1e170a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f1ac506386240df4b11c789526952e |
| publicationDate |
2005-03-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005048109-A1 |
| titleOfInvention |
Non-polar photosensitizer formulations for photodynamic therapy |
| abstract |
A pharmaceutical liposomal formulation for photodynamic therapy comprising a non-polar porphyrin photosensitizer and one or more phospholipids, which are stable in storage without requiring freeze-drying is described. The liposomal formulation provides therapeutically effective amounts of the photosensitizer for intravenous administration. The phospholipids may be modified by pegylation, i.e. they contain poly ethylene glycol as an integral part of the phospholipids. The formed liposomes contain the non-polar photosensitizer within the membrane and are useful for the combined targeting of a non-polar photosensitizer and a second polar substance. When a formulation includes the presence of monosaccharides or polyalcohols, it can be efficiently freeze-dried preserving the size of the liposomal vehicles and the content of a therapeutically effective amount of the photosensitizing agent. The invention also relates to the liposome composition formed upon reconstitution with an aqueous vehicle. The freeze-dried formulation upon reconstitution with a suitable aqueous vehicle forms liposomes that are also useful for intravenous administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10004687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10182997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2034963-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008214460-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2051699-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008138400-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2034963-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2051699-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006067998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007084468-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102432755-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008103213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011021973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009163849-A1 |
| priorityDate |
2003-08-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |